Quadratech Diagnostics, a provider of high quality medical diagnostics and research products, announced a global launch of Factor-X Activator RVV-X (50U) as the latest addition to the Q-TOX range of ...

There are currently no FDA-approved treatments for FXS, a disease that affects approximately 1 in 4-5000 men and 1 in 6-8000 women globally.